Finity company information, Employees & Contact Information

Finity and Ortec Finance partner to offer advanced climate scenario analysis for investment portfolios finity.com.au

Finity launches new AI powered classification software platform - Classifi | News and Insights - Finity Consulting finity.com.au

Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people Airfinity

Optima In Focus Webinar: Commercial Lines - a summary finity.com.au

Portia Elliott: balancing traditional actuarial and climate work finity.com.au

China’s second COVID-19 wave to be smaller than its first peaking at 11 million cases a week, predicts Airfinity Airfinity

Chintan Sapariya: growth as an actuary finity.com.au

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity Airfinity

‘Tripledemic’ peak in US and UK hospitalisations to be smaller than last year as new COVID waves start in both countries Airfinity

Australia’s first National Climate Risk Assessment finity.com.au

France could see local dengue cases rise 50-fold by 2030 as temperatures rise Airfinity

Navigating the Insurtech Landscape finity.com.au

Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific Ocean Airfinity

The Pulsepoint Platform finity.com.au

The West should be on a war footing for the next pandemic Airfinity

Sophie Howard: "where people want to be" finity.com.au

Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes Airfinity

Classifi | Products finity.com.au

Reconciliation Action Plan finity.com.au

Meet Finity Principal Adam Payne | News and Insights - Finity Consulting finity.com.au

Is the world prepared for a potential H5N1 bird flu pandemic? Airfinity

Airfinity’s COVID-19 forecast for China infections and deaths Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases Airfinity

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir Airfinity

US FDA has extended the PDUFA target date for Legend Biotech/Janssen’s Cilta-Cel from November 29, 2021, to February 28, 2022. Airfinity

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe Airfinity

Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death Airfinity

Elderly RSV vaccines to generate $10.5B annually by 2030 in G7 countries Airfinity

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market Airfinity

Finity launches new cloud-based end-to-end underwriting platform – Uniwriter | News and Insights - Finity Consulting finity.com.au

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers Airfinity

GSK releases positive data on its RSV vaccine for older adults, RSV OA Airfinity

Airfinity launches new platform IDA to track all infectious disease vaccine and treatment candidates Airfinity

300% rise in approved new cancer treatments in the last two decades, with US cancer moonshot goal achievable by 2048 Airfinity

COVID-19 vaccine makers raise prices to off set falling revenue as demand for jabs drops Airfinity

Case study: How Uniwriter helps businesses finity.com.au

A strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8% Airfinity

Comparing the burden of COVID-19 to seasonal flu: what does the data say? Airfinity

China’s COVID-19 wave forecast to have two peaks where cases could reach 4.2 million a day Airfinity

Global wastage of COVID-19 vaccines could be 1.1 billion doses Airfinity

Moderna more effective than Pfizer in direct comparison against the Delta variant Airfinity

Commitment to diversity, equality and inclusion finity.com.au

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination Airfinity

China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy Airfinity

COVID-19 vaccine market forecast to grow 29% to $84.9B in 2022, according to Airfinity Airfinity

Finity Consulting finity.com.au

Corporate social responsibility finity.com.au

Actuarial & Analytics Graduates | Careers finity.com.au

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue Airfinity

Finity Graduate Program 2025 | Careers finity.com.au

Risk management insights for private health insurers finity.com.au

Vantage allows intermediated insurers to finity.com.au

Injury & care schemes finity.com.au

Why even the smartest AI is missing the name game Forbes Australia

Winds of change in the NDIS: what does it mean for injury schemes? finity.com.au

NSW Floods – a delicate balance finity.com.au

Physical Climate Risk Assessment for the Local Aboriginal Land Council in Brewarrina: A pro-bono project, part of Finity’s Reconciliation Action Plan | News and Insights finity.com.au

Mutual bank mergers: an inevitable trend? | News and Insights finity.com.au

The Cost of Mental Injury Claims in Queensland finity.com.au

The postcodes most vulnerable to severe COVID-19 consequences 9News